期刊文献+

lipstatin发酵工艺的优化 被引量:4

Fermentation Process Optimization of Lipstatin
下载PDF
导出
摘要 目的优化lipstatin的发酵工艺。方法采用摇瓶发酵,改变实验条件,通过测定lipstatin含量来确定较为适合的发酵工艺。结果优化后的培养基组成为:豆油8.0%,甘油0.7%,黄豆粉3.0%,酵母粉1.0%,TritonX-100 0.1%。在此条件下lipstatin发酵产量为156.8 mg/L。结论提高了lipstatin产量。 Objective To optimize the fermentation process of lipstatin. Methods In shaken flask culture, the yield of lipstatin was determined under the different experiment conditions in order to obtain an optimal fermentation process. Results The optimal medium contained 8.0 % bean oil, 0.7 % glycerol, 3.0 % soybean powder, 1.0 % yeast extract powder, 0.1% TritonX-100. The yield of lipstatin was 156.8 mg/L. Conclusion The yield of lipstatin can be improved.
出处 《食品与药品》 CAS 2007年第12A期5-7,共3页 Food and Drug
关键词 lipstatin 毒三素链霉菌 发酵工艺 lipstatin Streptomyces toxytricini fermentation process
  • 相关文献

参考文献6

  • 1韩俊茹,史毓芳,陈金龙,钱俊青.利普司他汀发酵工艺研究[J].浙江工业大学学报,2006,34(2):141-144. 被引量:3
  • 2Weibel E K, Hadyary P, Hochuli E. Lipstatin, an inhibitor of pancreatic lipase, produced by Streptomyces toxytrcini. I. producting organism, fermentation, isolation and biological activity[J]. J Antibiotics, 1987, XL (8): 1081-1080
  • 3Weibel E K, Hadyary P, Hochuli E. Lipstatin, an inhibitor of pancreatic lipase, produced by Streptomyces toxytrcini. Ⅱ. chemistry and structure elucidation[J], J Antibiotics, 1987, XL(8): 1086-1095.
  • 4Wendy M, Paul B. Olistatat[J]. Drugs, 1998, 56(2): 241-249.
  • 5茆永康,陈代杰,黄为一.表面活性剂PEG600对毒三素链霉菌发酵的影响[J].中国抗生素杂志,2005,30(11):649-652. 被引量:2
  • 6王栋海.Lipstatin的开发与研究[D].上海:上海师范大学微生物学,2004,

二级参考文献7

  • 1Markus G, Wolfgang E, Adelbert B, et al. Biosynthetic origin of hydrogen atoms in the lipase inhibitor lipstatin [J]. J Biol Chem,2000,275(28):21192.
  • 2Markus G, Wolfgang E, Adelbert B, et al. Biosynthesis of lipstatin [J]. J Org Chem, 2001,66 (13): 4668.
  • 3MELIA A T,ZHI J,ZE I R,et al.The interaction of the lipose inhibitor orlistat with ethanol in healthy volunteers[J].Eur J Clin Pharmacol,1998,54 (9-10):773-775.
  • 4HOLLANDER P A,ELBEIN S C,HIRSCH I B,et al.Role of orlistat in the treatment of obese patients with type 2 diabetes[J].DIABETES CARE,1998,21(8):1288-1289.
  • 5HADVARY P,HANS L,HELMUT W.Inhibition of pancreatic lipase in vitro by the covalent inhibitor tetrdrolipstatin[J].Biochem J,1998,256:357-361.
  • 6MARKUS G.,WOLFGANG E,ADELBERT B,et al.Biosynthesis of lipstatin[J].J Org Chem,2001,66 (13):4668-5677.
  • 7方开泰,马长兴.正交与均匀设计实验[M].北京:科学出版社,2001.

共引文献3

同被引文献36

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部